| Autor: |
Frey B; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany. bryan.frey@abbvie.com.; Department of Neurology, Hannover Medical School, Hanover, Germany. bryan.frey@abbvie.com.; Center for Systems Neuroscience, Hannover, Germany. bryan.frey@abbvie.com., Holzinger D; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Taylor K; AbbVie Bioresearch Center, Biotherapeutics and Genetic Medicine Technologies, Worcester, MA, USA., Ehrnhoefer DE; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Striebinger A; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Biesinger S; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Gasparini L; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., O'Neill MJ; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Wegner F; Department of Neurology, Hannover Medical School, Hanover, Germany.; Center for Systems Neuroscience, Hannover, Germany., Barghorn S; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany., Höglinger GU; Department of Neurology, Hannover Medical School, Hanover, Germany.; Center for Systems Neuroscience, Hannover, Germany.; German Center for Neurodegenerative Diseases E.V. (DZNE), Munich, Germany.; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-University (LMU), Munich, Germany., Heym RG; AbbVie Deutschland GmbH & Co. KG, Neuroscience Research, Knollstrasse, 67061, Ludwigshafen, Germany. roland.heym@abbvie.com. |
